Details for Patent: 9,700,555

Which drugs does patent 9,700,555 protect, and when does it expire?

Patent 9,700,555 protects CYCLOSET and is included in one NDA.

This patent has twenty-one patent family members in twelve countries.

Summary for Patent: 9,700,555

Title:	Bromocriptine formulations
Abstract:	The present application describes pharmaceutical formulations of bromocriptine mesylate and methods of manufacturing and using such formulations. The formulations are useful for improving glycemic control in the treatment of type 2 diabetes.
Inventor(s):	Cincotta; Anthony H. (Tiverton, RI), Bowe; Craig Michael (Encinitas, CA), Stearns; Paul Clark (San Diego, CA), Weston; Laura Jean (Escondido, CA)
Assignee:	VeroScience LLC (Tiverton, RI)
Application Number:	15/286,826
Patent Claim Types: see list of patent claims	Use; Composition; Formulation; Compound; Delivery; Dosage form;

Understanding the Scope and Claims of United States Patent 9,700,555: A Comprehensive Analysis

Introduction to Patent 9,700,555

United States Patent 9,700,555, hereafter referred to as the '555 patent, is a specific patent that has been granted by the U.S. Patent and Trademark Office (USPTO). To analyze this patent, it is crucial to understand the broader context of the patent system, the tools available for patent research, and the specific details of the patent itself.

The U.S. Patent and Trademark Office (USPTO)

The USPTO is the agency responsible for granting U.S. patents and registering trademarks. It provides various resources and tools to facilitate patent searches and analyses[2].

Tools for Patent Research

Global Dossier

The Global Dossier service is a valuable tool for patent researchers. It allows users to access the file histories of related applications from participating IP Offices, including the IP5 Offices. This service provides a comprehensive view of the patent family, including classification, citation data, and Office Action Indicators[1].

Public Search Facility

The USPTO Public Search Facility in Alexandria, VA, offers public access to patent and trademark information in various formats, including online, microfilm, and print. Trained staff are available to assist users in their searches[1].

Patent and Trademark Resource Centers (PTRCs)

PTRCs are local resources that maintain search materials and may offer training in patent search techniques. These centers are essential for individuals who need hands-on assistance with patent searches[1].

Common Citation Document (CCD)

The CCD application consolidates prior art citations from all participating IP5 Offices for a patent application family. This tool helps in visualizing search results from multiple offices on a single page, facilitating a more integrated global patent system[1].

Patent Claims Research Dataset

The Patent Claims Research Dataset, provided by the USPTO, contains detailed information on claims from U.S. patents granted between 1976 and 2014 and U.S. patent applications published between 2001 and 2014. This dataset is crucial for analyzing patent scope and claim dependencies[3].

Analyzing Patent 9,700,555

Patent Details

To analyze the '555 patent, one would typically start by accessing the patent document through the USPTO's public search facilities or online databases.

Title and Abstract

The title and abstract provide a brief overview of the invention. Understanding these elements is essential for grasping the patent's scope and claims.

Claims

The claims section is the most critical part of a patent, as it defines the legal boundaries of the invention. Each claim must be clear, concise, and fully supported by the description.

Description and Drawings

The description and drawings provide detailed information about the invention, including its components, functionality, and any variations or embodiments.

Claim Analysis

Independent and Dependent Claims

Independent claims stand alone and define the invention without reference to other claims. Dependent claims, on the other hand, refer back to and further limit the independent claims.

Claim Scope

The scope of the claims determines the extent of protection granted by the patent. Broader claims may offer more protection but are also more likely to be challenged for lack of novelty or non-obviousness.

Prior Art and Citations

Common Citation Document (CCD)

Using the CCD, one can identify prior art cited by all participating offices for the '555 patent family. This helps in understanding how the patent office viewed the novelty and non-obviousness of the invention.

Office Actions

Office Action Indicators in the Global Dossier can highlight any office actions related to the patent, providing insight into the examination process and any challenges faced during the granting of the patent.

Economic and Litigation Context

Patent Litigation Trends

Research by the Government Accountability Office (GAO) has identified factors that contribute to patent infringement litigation. Understanding these trends can provide context on the potential risks and challenges associated with the '555 patent[4].

Small Claims Patent Court

The concept of a small claims patent court, as studied by the Administrative Conference of the United States (ACUS), could impact how future patent disputes are handled. This might affect the enforcement and defense strategies related to patents like the '555 patent[5].

Practical Applications and Implications

Licensing and Enforcement

The claims and scope of the '555 patent determine its value and enforceability. Companies or individuals holding this patent must ensure that their licensing agreements and enforcement strategies align with the defined claims.

Innovation and Competition

The '555 patent's impact on innovation and competition within its industry can be significant. It may either encourage further innovation by protecting novel ideas or stifle competition if the claims are overly broad.

Key Takeaways

• Comprehensive Search Tools: Utilize tools like the Global Dossier, Public Search Facility, and CCD to gather detailed information about the patent.
• Claim Analysis: Carefully review the independent and dependent claims to understand the patent's scope and boundaries.
• Prior Art and Citations: Analyze prior art and citations to assess the novelty and non-obviousness of the invention.
• Economic and Litigation Context: Consider broader trends in patent litigation and potential changes in the legal landscape.
• Practical Applications: Ensure that licensing and enforcement strategies align with the patent's claims and scope.

FAQs

Q: How can I access the full text of United States Patent 9,700,555?

A: You can access the full text of the patent through the USPTO's public search facilities or online databases such as the USPTO's Patent Full-Text and Image Database (PatFT).

Q: What is the significance of the Common Citation Document (CCD) in patent research?

A: The CCD consolidates prior art citations from all participating IP5 Offices, allowing users to visualize search results from multiple offices on a single page.

Q: How do I determine the scope of a patent's claims?

A: The scope of a patent's claims is determined by carefully reviewing the independent and dependent claims, as well as any limitations or embodiments described in the patent document.

Q: What role does the Global Dossier play in patent research?

A: The Global Dossier provides access to the file histories of related applications from participating IP Offices, including classification, citation data, and Office Action Indicators.

Q: How might changes in patent litigation trends affect the enforcement of a patent like the '555 patent?

A: Changes in patent litigation trends, such as the potential establishment of a small claims patent court, could impact how patent disputes are handled, affecting enforcement and defense strategies.

Sources

1. USPTO - Search for patents: https://www.uspto.gov/patents/search
2. USA.gov - U.S. Patent and Trademark Office (USPTO): https://www.usa.gov/agencies/u-s-patent-and-trademark-office
3. USPTO - Patent Claims Research Dataset: https://www.uspto.gov/ip-policy/economic-research/research-datasets/patent-claims-research-dataset
4. GAO - Assessing Factors That Affect Patent Infringement Litigation: https://www.gao.gov/products/gao-13-465
5. ACUS - U.S. Patent Small Claims Court: https://www.acus.gov/research-projects/us-patent-small-claims-court

Drugs Protected by US Patent 9,700,555

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Veroscience	CYCLOSET	bromocriptine mesylate	TABLET;ORAL	020866-001	May 5, 2009		RX	Yes	Yes			Y			ADJUNCT TO DIET AND EXERCISE TO IMPROVE GLYCEMIC CONTROL IN ADULTS WITH TYPE 2 DIABETES BY ORALLY ADMINISTERING A DOSAGE FORM COMPRISING BROMOCRIPTINE AND ONE OR MORE EXCIPIENTS AS RECITED IN CLAIMS 41, 52, AND 53
Veroscience	CYCLOSET	bromocriptine mesylate	TABLET;ORAL	020866-001	May 5, 2009		RX	Yes	Yes			Y			ADJUNCT TO DIET AND EXERCISE TO IMPROVE GLYCEMIC CONTROL IN ADULTS WITH TYPE 2 DIABETES BY ADMINISTERING A DOSAGE FORM COMPRISING MICRONIZED BROMOCRIPTINE AND ONE OR MORE EXCIPIENTS AS RECITED IN CLAIMS 66, 75, AND 76
Veroscience	CYCLOSET	bromocriptine mesylate	TABLET;ORAL	020866-001	May 5, 2009		RX	Yes	Yes			Y			ADJUNCT TO DIET AND EXERCISE TO IMPROVE GLYCEMIC CONTROL IN ADULTS WITH TYPE 2 DIABETES BY ORALLY ADMINISTERING A DOSAGE FORM COMPRISING BROMOCRIPTINE AND ONE OR MORE EXCIPIENTS AS RECITED IN CLAIMS 29, 39, AND 40
Veroscience	CYCLOSET	bromocriptine mesylate	TABLET;ORAL	020866-001	May 5, 2009		RX	Yes	Yes			Y			ADJUNCT TO DIET AND EXERCISE TO IMPROVE GLYCEMIC CONTROL IN ADULTS WITH TYPE 2 DIABETES BY ORALLY ADMINISTERING A DOSAGE FORM COMPRISING BROMOCRIPTINE AND ONE OR MORE EXCIPIENTS AS RECITED IN CLAIMS 1, 13, AND 14
Veroscience	CYCLOSET	bromocriptine mesylate	TABLET;ORAL	020866-001	May 5, 2009		RX	Yes	Yes			Y			ADJUNCT TO DIET AND EXERCISE TO IMPROVE GLYCEMIC CONTROL IN ADULTS WITH TYPE 2 DIABETES BY ORALLY ADMINISTERING A DOSAGE FORM COMPRISING BROMOCRIPTINE AND ONE OR MORE EXCIPIENTS AS RECITED IN CLAIMS 54 AND 64
Veroscience	CYCLOSET	bromocriptine mesylate	TABLET;ORAL	020866-001	May 5, 2009		RX	Yes	Yes			Y			ADJUNCT TO DIET AND EXERCISE TO IMPROVE GLYCEMIC CONTROL IN ADULTS WITH TYPE 2 DIABETES BY ORALLY ADMINISTERING A DOSAGE FORM COMPRISING BROMOCRIPTINE AND ONE OR MORE EXCIPIENTS AS RECITED IN CLAIMS 29 AND 39
Veroscience	CYCLOSET	bromocriptine mesylate	TABLET;ORAL	020866-001	May 5, 2009		RX	Yes	Yes			Y			ADJUNCT TO DIET AND EXERCISE TO IMPROVE GLYCEMIC CONTROL IN ADULTS WITH TYPE 2 DIABETES BY ORALLY ADMINISTERING A DOSAGE FORM COMPRISING BROMOCRIPTINE AND ONE OR MORE EXCIPIENTS AS RECITED IN CLAIMS 1 AND 13

International Family Members for US Patent 9,700,555

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Argentina	091351
Australia	2013256558
Australia	2016202572
Australia	2018203021
Brazil	112014027087
Canada	2872300
European Patent Office	2844229